PBM
Propel Bio Management’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.85M | Sell |
922,927
-212,000
| -19% | -$2.03M | 10.74% | 4 |
|
|
2025
Q1 | $7.12M | Buy |
1,134,927
+145,000
| +15% | +$909K | 8.27% | 4 |
|
|
2024
Q4 | $8.04M | Buy |
989,927
+120,000
| +14% | +$974K | 7.98% | 6 |
|
|
2024
Q3 | $15.7M | Hold |
869,927
| – | – | 9.12% | 3 |
|
|
2024
Q2 | $8.96M | Hold |
869,927
| – | – | 5.81% | 6 |
|
|
2024
Q1 | $9.24M | Buy |
869,927
+426,880
| +96% | +$4.53M | 5.38% | 6 |
|
|
2023
Q4 | $4.05M | Buy |
+443,047
| New | +$4.05M | 3.35% | 8 |
|